{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T13:17:49Z","timestamp":1761311869729,"version":"3.37.3"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2022,3,7]],"date-time":"2022-03-07T00:00:00Z","timestamp":1646611200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,3,7]],"date-time":"2022-03-07T00:00:00Z","timestamp":1646611200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Neurochir"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1007\/s00701-022-05170-5","type":"journal-article","created":{"date-parts":[[2022,3,7]],"date-time":"2022-03-07T21:02:28Z","timestamp":1646686948000},"page":"1365-1373","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Diagnosis, treatment, and outcome of primary CNS lymphoma\u2014a single-center experience"],"prefix":"10.1007","volume":"164","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4658-9805","authenticated-orcid":false,"given":"Joakim","family":"Wismann","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rune H\u00f8rlykke","family":"Sommer-S\u00f8rensen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6819-4345","authenticated-orcid":false,"given":"Mikkel Seremet","family":"Kofoed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bo","family":"Halle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian Bonde","family":"Pedersen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mette Katrine","family":"Schulz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mads Hjortdal","family":"Gr\u00f8nh\u00f8j","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8418-6708","authenticated-orcid":false,"given":"Thomas Stauffer","family":"Larsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2041-3630","authenticated-orcid":false,"given":"Michael Boe","family":"M\u00f8ller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5715-6901","authenticated-orcid":false,"given":"Frantz Rom","family":"Poulsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,3,7]]},"reference":[{"issue":"22","key":"5170_CR1","doi-asserted-by":"publisher","first-page":"5034","DOI":"10.1200\/JCO.2005.13.524","volume":"23","author":"LE Abrey","year":"2005","unstructured":"Abrey LE, Batchelor TT, Ferreri AJ, Gospodarowicz M, Pulczynski EJ, Zucca E, Smith JR, Korfel A, Soussain C, DeAngelis LM, Neuwelt EA, O\u2019Neill BP, Thiel E, Shenkier T, Graus F, van den Bent M, Seymour JF, Poortmans P, Armitage JO, Cavalli F, International Primary CNSLCG (2005) Report of an international workshop to standardize baseline evaluation and response criteria for primary CNS lymphoma. J Clin Oncol 23(22):5034\u20135043. https:\/\/doi.org\/10.1200\/JCO.2005.13.524","journal-title":"J Clin Oncol"},{"issue":"36","key":"5170_CR2","doi-asserted-by":"publisher","first-page":"5711","DOI":"10.1200\/JCO.2006.08.2941","volume":"24","author":"LE Abrey","year":"2006","unstructured":"Abrey LE, Ben-Porat L, Panageas KS, Yahalom J, Berkey B, Curran W, Schultz C, Leibel S, Nelson D, Mehta M, DeAngelis LM (2006) Primary central nervous system lymphoma: the Memorial Sloan-Kettering Cancer Center prognostic model. J Clin Oncol 24(36):5711\u20135715. https:\/\/doi.org\/10.1200\/JCO.2006.08.2941","journal-title":"J Clin Oncol"},{"issue":"11","key":"5170_CR3","doi-asserted-by":"publisher","first-page":"2665","DOI":"10.3390\/cancers13112665","volume":"13","author":"A Baraniskin","year":"2021","unstructured":"Baraniskin A, Schroers R (2021) Liquid biopsy and other non-invasive diagnostic measures in PCNSL. Cancers (Basel) 13(11):2665. https:\/\/doi.org\/10.3390\/cancers13112665","journal-title":"Cancers (Basel)"},{"issue":"3","key":"5170_CR4","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1016\/s0360-3016(97)00571-3","volume":"41","author":"J Corry","year":"1998","unstructured":"Corry J, Smith JG, Wirth A, Quong G, Liew KH (1998) Primary central nervous system lymphoma: age and performance status are more important than treatment modality. Int J Radiat Oncol Biol Phys 41(3):615\u2013620. https:\/\/doi.org\/10.1016\/s0360-3016(97)00571-3","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"5170_CR5","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1007\/s003300101037","volume":"12","author":"A Coulon","year":"2002","unstructured":"Coulon A, Lafitte F, Hoang-Xuan K, Martin-Duverneuil N, Mokhtari K, Blustajn J, Chiras J (2002) Radiographic findings in 37 cases of primary CNS lymphoma in immunocompetent patients. Eur Radiol 12(2):329\u2013340. https:\/\/doi.org\/10.1007\/s003300101037","journal-title":"Eur Radiol"},{"issue":"1","key":"5170_CR6","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1111\/ejh.12980","volume":"100","author":"S Eloranta","year":"2018","unstructured":"Eloranta S, Branvall E, Celsing F, Papworth K, Ljungqvist M, Enblad G, Ekstrom-Smedby K (2018) Increasing incidence of primary central nervous system lymphoma but no improvement in survival in Sweden 2000\u20132013. Eur J Haematol 100(1):61\u201368. https:\/\/doi.org\/10.1111\/ejh.12980","journal-title":"Eur J Haematol"},{"issue":"17","key":"5170_CR7","doi-asserted-by":"publisher","first-page":"1891","DOI":"10.1001\/jama.2011.1592","volume":"306","author":"EA Engels","year":"2011","unstructured":"Engels EA, Pfeiffer RM, Fraumeni JF Jr, Kasiske BL, Israni AK, Snyder JJ, Wolfe RA, Goodrich NP, Bayakly AR, Clarke CA, Copeland G, Finch JL, Fleissner ML, Goodman MT, Kahn A, Koch L, Lynch CF, Madeleine MM, Pawlish K, Rao C, Williams MA, Castenson D, Curry M, Parsons R, Fant G, Lin M (2011) Spectrum of cancer risk among US solid organ transplant recipients. JAMA 306(17):1891\u20131901. https:\/\/doi.org\/10.1001\/jama.2011.1592","journal-title":"JAMA"},{"issue":"2","key":"5170_CR8","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1200\/JCO.2003.09.139","volume":"21","author":"AJ Ferreri","year":"2003","unstructured":"Ferreri AJ, Blay JY, Reni M, Pasini F, Spina M, Ambrosetti A, Calderoni A, Rossi A, Vavassori V, Conconi A, Devizzi L, Berger F, Ponzoni M, Borisch B, Tinguely M, Cerati M, Milani M, Orvieto E, Sanchez J, Chevreau C, Dell\u2019Oro S, Zucca E, Cavalli F (2003) Prognostic scoring system for primary CNS lymphomas: the International Extranodal Lymphoma Study Group experience. J Clin Oncol 21(2):266\u2013272. https:\/\/doi.org\/10.1200\/JCO.2003.09.139","journal-title":"J Clin Oncol"},{"issue":"1","key":"5170_CR9","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1182\/asheducation-2017.1.565","volume":"2017","author":"AJM Ferreri","year":"2017","unstructured":"Ferreri AJM (2017) Therapy of primary CNS lymphoma: role of intensity, radiation, and novel agents. Hematol Am Soc Hematol Educ Program 2017(1):565\u2013577. https:\/\/doi.org\/10.1182\/asheducation-2017.1.565","journal-title":"Hematol Am Soc Hematol Educ Program"},{"issue":"9","key":"5170_CR10","doi-asserted-by":"publisher","first-page":"2080","DOI":"10.1093\/annonc\/mdq712","volume":"22","author":"K Fritsch","year":"2011","unstructured":"Fritsch K, Kasenda B, Hader C, Nikkhah G, Prinz M, Haug V, Haug S, Ihorst G, Finke J, Illerhaus G (2011) Immunochemotherapy with rituximab, methotrexate, procarbazine, and lomustine for primary CNS lymphoma (PCNSL) in the elderly. Ann Oncol 22(9):2080\u20132085. https:\/\/doi.org\/10.1093\/annonc\/mdq712","journal-title":"Ann Oncol"},{"issue":"21","key":"5170_CR11","doi-asserted-by":"publisher","first-page":"2410","DOI":"10.1200\/JCO.2017.72.7602","volume":"35","author":"C Grommes","year":"2017","unstructured":"Grommes C, DeAngelis LM (2017) Primary CNS Lymphoma. J Clin Oncol 35(21):2410\u20132418. https:\/\/doi.org\/10.1200\/JCO.2017.72.7602","journal-title":"J Clin Oncol"},{"issue":"4","key":"5170_CR12","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1007\/s10143-018-0946-0","volume":"41","author":"G Jahr","year":"2018","unstructured":"Jahr G, Da Broi M, Holte H Jr, Beiske K, Meling TR (2018) The role of surgery in intracranial PCNSL. Neurosurg Rev 41(4):1037\u20131044. https:\/\/doi.org\/10.1007\/s10143-018-0946-0","journal-title":"Neurosurg Rev"},{"issue":"3\u20134","key":"5170_CR13","doi-asserted-by":"publisher","first-page":"223","DOI":"10.3109\/10428199509107892","volume":"19","author":"M Krogh-Jensen","year":"1995","unstructured":"Krogh-Jensen M, D\u2019Amore F, Jensen MK, Christensen BE, Thorling K, Pedersen M, Johansen P, Boesen AM, Andersen E (1995) Clinicopathological features, survival and prognostic factors of primary central nervous system lymphomas: trends in incidence of primary central nervous system lymphomas and primary malignant brain tumors in a well-defined geographical area. Population-based data from the Danish Lymphoma Registry, LYFO, and the Danish Cancer Registry. Leuk Lymphoma 19(3\u20134):223\u2013233. https:\/\/doi.org\/10.3109\/10428199509107892","journal-title":"Leuk Lymphoma"},{"issue":"2","key":"5170_CR14","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1111\/ajt.14465","volume":"18","author":"P Mahale","year":"2018","unstructured":"Mahale P, Shiels MS, Lynch CF, Engels EA (2018) Incidence and outcomes of primary central nervous system lymphoma in solid organ transplant recipients. Am J Transplant 18(2):453\u2013461. https:\/\/doi.org\/10.1111\/ajt.14465","journal-title":"Am J Transplant"},{"issue":"5","key":"5170_CR15","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1093\/neuonc\/nox187","volume":"20","author":"JS Mendez","year":"2018","unstructured":"Mendez JS, Ostrom QT, Gittleman H, Kruchko C, DeAngelis LM, Barnholtz-Sloan JS, Grommes C (2018) The elderly left behind-changes in survival trends of primary central nervous system lymphoma over the past 4 decades. Neuro Oncol 20(5):687\u2013694. https:\/\/doi.org\/10.1093\/neuonc\/nox187","journal-title":"Neuro Oncol"},{"issue":"6","key":"5170_CR16","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1093\/nop\/npz015","volume":"6","author":"AA Morell","year":"2019","unstructured":"Morell AA, Shah AH, Cavallo C, Eichberg DG, Sarkiss CA, Benveniste R, Ivan ME, Komotar RJ (2019) Diagnosis of primary central nervous system lymphoma: a systematic review of the utility of CSF screening and the role of early brain biopsy. Neurooncol Pract 6(6):415\u2013423. https:\/\/doi.org\/10.1093\/nop\/npz015","journal-title":"Neurooncol Pract"},{"issue":"1","key":"5170_CR17","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/s13000-019-0833-1","volume":"14","author":"P Niparuck","year":"2019","unstructured":"Niparuck P, Boonsakan P, Sutthippingkiat T, Pukiat S, Chantrathammachart P, Phusanti S, Boonyawat K, Puavilai T, Angchaisuksiri P, Ungkanont A, Chuncharunee S, Atichartakarn V (2019) Treatment outcome and prognostic factors in PCNSL. Diagn Pathol 14(1):56. https:\/\/doi.org\/10.1186\/s13000-019-0833-1","journal-title":"Diagn Pathol"},{"issue":"6","key":"5170_CR18","doi-asserted-by":"publisher","first-page":"e251","DOI":"10.1016\/S2352-3026(15)00074-5","volume":"2","author":"A Omuro","year":"2015","unstructured":"Omuro A, Chinot O, Taillandier L, Ghesquieres H, Soussain C, Delwail V, Lamy T, Gressin R, Choquet S, Soubeyran P, Huchet A, Benouaich-Amiel A, Lebouvier-Sadot S, Gyan E, Touitou V, Barrie M, del Rio MS, Gonzalez-Aguilar A, Houillier C, Delgadillo D, Lacomblez L, Tanguy ML, Hoang-Xuan K (2015) Methotrexate and temozolomide versus methotrexate, procarbazine, vincristine, and cytarabine for primary CNS lymphoma in an elderly population: an intergroup ANOCEF-GOELAMS randomised phase 2 trial. Lancet Haematol 2(6):e251-259. https:\/\/doi.org\/10.1016\/S2352-3026(15)00074-5","journal-title":"Lancet Haematol"},{"issue":"12","key":"5170_CR19","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1002\/ajh.23551","volume":"88","author":"BP O'Neill","year":"2013","unstructured":"O\u2019Neill BP, Decker PA, Tieu C, Cerhan JR (2013) The changing incidence of primary central nervous system lymphoma is driven primarily by the changing incidence in young and middle-aged men and differs from time trends in systemic diffuse large B-cell non-Hodgkin\u2019s lymphoma. Am J Hematol 88(12):997\u20131000. https:\/\/doi.org\/10.1002\/ajh.23551","journal-title":"Am J Hematol"},{"issue":"Suppl 4","key":"5170_CR20","doi-asserted-by":"publisher","first-page":"iv1","DOI":"10.1093\/neuonc\/nov189","volume":"17","author":"QT Ostrom","year":"2015","unstructured":"Ostrom QT, Gittleman H, Fulop J, Liu M, Blanda R, Kromer C, Wolinsky Y, Kruchko C, Barnholtz-Sloan JS (2015) CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2008\u20132012. Neuro Oncol 17(Suppl 4):iv1\u2013iv62. https:\/\/doi.org\/10.1093\/neuonc\/nov189","journal-title":"Neuro Oncol"},{"issue":"suppl_5","key":"5170_CR21","doi-asserted-by":"publisher","first-page":"v1","DOI":"10.1093\/neuonc\/nox158","volume":"19","author":"QT Ostrom","year":"2017","unstructured":"Ostrom QT, Gittleman H, Liao P, Vecchione-Koval T, Wolinsky Y, Kruchko C, Barnholtz-Sloan JS (2017) CBTRUS Statistical Report: primary brain and other central nervous system tumors diagnosed in the United States in 2010\u20132014. Neuro Oncol 19(suppl_5):v1\u2013v88. https:\/\/doi.org\/10.1093\/neuonc\/nox158","journal-title":"Neuro Oncol"},{"issue":"8","key":"5170_CR22","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1038\/bmt.2017.23","volume":"52","author":"E Schorb","year":"2017","unstructured":"Schorb E, Fox CP, Fritsch K, Isbell L, Neubauer A, Tzalavras A, Witherall R, Choquet S, Kuittinen O, De-Silva D, Cwynarski K, Houillier C, Hoang-Xuan K, Touitou V, Cassoux N, Marolleau JP, Tamburini J, Houot R, Delwail V, Illerhaus G, Soussain C, Kasenda B (2017) High-dose thiotepa-based chemotherapy with autologous stem cell support in elderly patients with primary central nervous system lymphoma: a European retrospective study. Bone Marrow Transplant 52(8):1113\u20131119. https:\/\/doi.org\/10.1038\/bmt.2017.23","journal-title":"Bone Marrow Transplant"},{"issue":"5","key":"5170_CR23","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1111\/bjh.16451","volume":"189","author":"E Schorb","year":"2020","unstructured":"Schorb E, Fox CP, Kasenda B, Linton K, Martinez-Calle N, Calimeri T, Ninkovic S, Eyre TA, Cummin T, Smith J, Yallop D, De Marco B, Krampera M, Trefz S, Orsucci L, Fabbri A, Illerhaus G, Cwynarski K, Ferreri AJM (2020) Induction therapy with the MATRix regimen in patients with newly diagnosed primary diffuse large B-cell lymphoma of the central nervous system - an international study of feasibility and efficacy in routine clinical practice. Br J Haematol 189(5):879\u2013887. https:\/\/doi.org\/10.1111\/bjh.16451","journal-title":"Br J Haematol"},{"issue":"5","key":"5170_CR24","doi-asserted-by":"publisher","first-page":"765","DOI":"10.3324\/haematol.2012.076075","volume":"98","author":"E Schorb","year":"2013","unstructured":"Schorb E, Kasenda B, Atta J, Kaun S, Morgner A, Hess G, Elter T, von Bubnoff N, Dreyling M, Ringhoffer M, Krause SW, Derigs G, Klimm B, Niemann D, Fritsch K, Finke J, Illerhaus G (2013) Prognosis of patients with primary central nervous system lymphoma after high-dose chemotherapy followed by autologous stem cell transplantation. Haematologica 98(5):765\u2013770. https:\/\/doi.org\/10.3324\/haematol.2012.076075","journal-title":"Haematologica"},{"issue":"3","key":"5170_CR25","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1001\/jamaneurol.2013.606","volume":"70","author":"BJ Scott","year":"2013","unstructured":"Scott BJ, Douglas VC, Tihan T, Rubenstein JL, Josephson SA (2013) A systematic approach to the diagnosis of suspected central nervous system lymphoma. JAMA Neurol 70(3):311\u2013319. https:\/\/doi.org\/10.1001\/jamaneurol.2013.606","journal-title":"JAMA Neurol"},{"key":"5170_CR26","doi-asserted-by":"publisher","DOI":"10.1111\/ejh.13639","author":"N Sieg","year":"2021","unstructured":"Sieg N, Naendrup JH, Godel P, Balke-Want H, Simon F, Deckert M, Gillessen S, Kreissl S, Brockelmann PJ, Borchmann P, von Tresckow B, Heger JM (2021) Treatment patterns and disease course of previously untreated Primary Central Nervous System Lymphoma - feasibility of MTX-based regimens in clinical routine. Eur J Haematol. https:\/\/doi.org\/10.1111\/ejh.13639","journal-title":"Eur J Haematol"},{"key":"5170_CR27","doi-asserted-by":"publisher","first-page":"e905","DOI":"10.1016\/j.wneu.2020.03.150","volume":"138","author":"X Zhou","year":"2020","unstructured":"Zhou X, Niu X, Li J, Zhang S, Yang W, Yang Y, Mao Q, Liu Y (2020) Risk factors for early mortality in patients with primary central nervous system lymphoma: a large-cohort retrospective study. World Neurosurg 138:e905\u2013e912. https:\/\/doi.org\/10.1016\/j.wneu.2020.03.150","journal-title":"World Neurosurg"}],"container-title":["Acta Neurochirurgica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00701-022-05170-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00701-022-05170-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00701-022-05170-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,2]],"date-time":"2022-05-02T14:31:43Z","timestamp":1651501903000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00701-022-05170-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,7]]},"references-count":27,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,5]]}},"alternative-id":["5170"],"URL":"https:\/\/doi.org\/10.1007\/s00701-022-05170-5","relation":{},"ISSN":["0942-0940"],"issn-type":[{"type":"electronic","value":"0942-0940"}],"subject":[],"published":{"date-parts":[[2022,3,7]]},"assertion":[{"value":"6 December 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 February 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 March 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This article does not contain any studies with human participants or animals performed by any of the authors. Regarding data collection from the health journal system, the study was approved by the Danish Health Authority (3\u20133013-3076\/1) and the Danish Data Protection Agency (19\/32776).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}